169 related articles for article (PubMed ID: 23089441)
1. Size of Stage IIIA primary lung cancers and survival: a surveillance, epidemiology and end results database analysis.
Maximus S; Nguyen DV; Mu Y; Calhoun RF; Cooke DT
Am Surg; 2012 Nov; 78(11):1232-7. PubMed ID: 23089441
[TBL] [Abstract][Full Text] [Related]
2. Recommended changes for T and N descriptors proposed by the International Association for the Study of Lung Cancer - Lung Cancer Staging Project: a validation study from a single-centre experience.
Ruffini E; Filosso PL; Bruna MC; Coni F; Cristofori RC; Mossetti C; Solidoro P; Oliaro A
Eur J Cardiothorac Surg; 2009 Dec; 36(6):1037-44. PubMed ID: 19692259
[TBL] [Abstract][Full Text] [Related]
3. Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system.
Carr SR; Schuchert MJ; Pennathur A; Wilson DO; Siegfried JM; Luketich JD; Landreneau RJ
J Thorac Cardiovasc Surg; 2012 Feb; 143(2):390-7. PubMed ID: 22169444
[TBL] [Abstract][Full Text] [Related]
4. Survival after lobectomy versus segmentectomy for stage I non-small cell lung cancer: a population-based analysis.
Whitson BA; Groth SS; Andrade RS; Maddaus MA; Habermann EB; D'Cunha J
Ann Thorac Surg; 2011 Dec; 92(6):1943-50. PubMed ID: 21962268
[TBL] [Abstract][Full Text] [Related]
5. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database.
Lally BE; Zelterman D; Colasanto JM; Haffty BG; Detterbeck FC; Wilson LD
J Clin Oncol; 2006 Jul; 24(19):2998-3006. PubMed ID: 16769986
[TBL] [Abstract][Full Text] [Related]
6. T2 tumors larger than five centimeters in diameter can be upgraded to T3 in non-small cell lung cancer.
Carbone E; Asamura H; Takei H; Kondo H; Suzuki K; Miyaoka E; Tsuchiya R; Motta G
J Thorac Cardiovasc Surg; 2001 Nov; 122(5):907-12. PubMed ID: 11689795
[TBL] [Abstract][Full Text] [Related]
7. The revised TNM staging system for lung cancer.
Rami-Porta R; Crowley JJ; Goldstraw P
Ann Thorac Cardiovasc Surg; 2009 Feb; 15(1):4-9. PubMed ID: 19262443
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the new TNM staging system proposed by the International Association for the Study of Lung Cancer at a single institution.
Kameyama K; Takahashi M; Ohata K; Igai H; Yamashina A; Matsuoka T; Nakagawa T; Okumura N
J Thorac Cardiovasc Surg; 2009 May; 137(5):1180-4. PubMed ID: 19379988
[TBL] [Abstract][Full Text] [Related]
9. Verification of the newly proposed T category (seventh edition of the tumor, node, and metastasis classification) from a clinicopathological viewpoint in non-small cell lung cancer-special reference to tumor size.
Yano T; Morodomi Y; Ito K; Yoshida T; Haro A; Shoji F; Koga T; Maehara Y
J Thorac Oncol; 2010 Jan; 5(1):45-8. PubMed ID: 19884855
[TBL] [Abstract][Full Text] [Related]
10. T1/T2 non-small-cell lung cancer treated by lobectomy: does tumor anatomic location matter?
Whitson BA; Groth SS; Andrade RS; Habermann EB; Maddaus MA; D'Cunha J
J Surg Res; 2012 Oct; 177(2):185-90. PubMed ID: 22921916
[TBL] [Abstract][Full Text] [Related]
11. Subcategorization of lung cancer based on tumor size and degree of visceral pleural invasion.
Sakakura N; Mori S; Okuda K; Fukui T; Hatooka S; Shinoda M; Matsuo K; Yatabe Y; Yokoi K; Mitsudomi T
Ann Thorac Surg; 2008 Oct; 86(4):1084-90. PubMed ID: 18805136
[TBL] [Abstract][Full Text] [Related]
12. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of intratumoral blood vessel invasion in pathologic stage IA non-small cell lung cancer.
Shoji F; Haro A; Yoshida T; Ito K; Morodomi Y; Yano T; Maehara Y
Ann Thorac Surg; 2010 Mar; 89(3):864-9. PubMed ID: 20172144
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of intratumoural microvascular invasion and microlymphatic permeation on node-negative non-small-cell lung cancer: which indicator is the stronger prognostic factor?
Hishida T; Yoshida J; Maeda R; Ishii G; Aokage K; Nishimura M; Nagai K
Eur J Cardiothorac Surg; 2013 Apr; 43(4):772-7. PubMed ID: 22864791
[TBL] [Abstract][Full Text] [Related]
15. Five-year survival does not equal cure in non-small cell lung cancer: a Surveillance, Epidemiology, and End Results-based analysis of variables affecting 10- to 18-year survival.
Hubbard MO; Fu P; Margevicius S; Dowlati A; Linden PA
J Thorac Cardiovasc Surg; 2012 Jun; 143(6):1307-13. PubMed ID: 22361247
[TBL] [Abstract][Full Text] [Related]
16. Definitive radiotherapy for stage I nonsmall cell lung cancer: a population-based study of survival.
Milano MT; Zhang H; Usuki KY; Singh DP; Chen Y
Cancer; 2012 Nov; 118(22):5572-9. PubMed ID: 22544655
[TBL] [Abstract][Full Text] [Related]
17. Factors predicting poor survival after resection of stage IA non-small cell lung cancer.
Chang MY; Mentzer SJ; Colson YL; Linden PA; Jaklitsch MT; Lipsitz SR; Sugarbaker DJ
J Thorac Cardiovasc Surg; 2007 Oct; 134(4):850-6. PubMed ID: 17903494
[TBL] [Abstract][Full Text] [Related]
18. Impact of large tumor size on survival after resection of pathologically node negative (pN0) non-small cell lung cancer.
Takeda S; Fukai S; Komatsu H; Nemoto E; Nakamura K; Murakami M;
Ann Thorac Surg; 2005 Apr; 79(4):1142-6. PubMed ID: 15797041
[TBL] [Abstract][Full Text] [Related]
19. The prognostic impact of tumor size in resected stage I non-small cell lung cancer: evidence for a two thresholds tumor diameters classification.
Christian C; Erica S; Morandi U
Lung Cancer; 2006 Nov; 54(2):185-91. PubMed ID: 16996167
[TBL] [Abstract][Full Text] [Related]
20. Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection.
Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
J Thorac Cardiovasc Surg; 2005 Jan; 129(1):87-93. PubMed ID: 15632829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]